Avalon GloboCare (NASDAQ:CHGA – Get Free Report) and Kinaxis (OTCMKTS:KXSCF – Get Free Report) are both technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability and earnings.
Valuation & Earnings
This table compares Avalon GloboCare and Kinaxis”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Avalon GloboCare | $1.26 million | 0.79 | -$18.26 million | ($13.80) | -0.06 |
| Kinaxis | $548.03 million | 8.06 | $70.70 million | $3.20 | 51.00 |
Profitability
This table compares Avalon GloboCare and Kinaxis’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Avalon GloboCare | N/A | N/A | -53.69% |
| Kinaxis | 14.35% | 22.31% | 12.48% |
Insider and Institutional Ownership
1.4% of Avalon GloboCare shares are held by institutional investors. 16.8% of Avalon GloboCare shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Analyst Ratings
This is a summary of current ratings and price targets for Avalon GloboCare and Kinaxis, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Avalon GloboCare | 1 | 0 | 0 | 0 | 1.00 |
| Kinaxis | 0 | 0 | 4 | 0 | 3.00 |
Summary
Kinaxis beats Avalon GloboCare on 10 of the 12 factors compared between the two stocks.
About Avalon GloboCare
Avalon GloboCare is a biotechnology and healthcare company whose activities have included developing cell-based therapies and precision diagnostic technologies. Its research has focused on applications in areas such as cancer and regenerative medicine. The company has worked on cell therapy approaches, including CAR-T and natural killer cell technologies, as well as diagnostic products and services. These activities have included research and development programs, rather than a broad portfolio of established therapies.
About Kinaxis
Kinaxis Inc. is a Canadian software company that develops cloud-based supply chain planning and management solutions. Its platform, Kinaxis Maestro, helps organizations coordinate planning across their supply chains and respond to changes in demand, supply and operations. Maestro supports activities such as demand and supply planning, inventory management, scenario analysis and sales and operations planning. The company also provides implementation, training and support services to help customers use its software.
Receive News & Ratings for Avalon GloboCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalon GloboCare and related companies with MarketBeat.com's FREE daily email newsletter.
